Sildenafil in the treatment of pulmonary hypertension

References

• AhnHSFosterMCableMCa/cam-stimulated and cgmp-specific phosphodiesterases in vascular and non-vascular tissuesAdv Exp Med Biol199130819171666264
   PubMedGoogle Scholar
• AlaeddiniJUberPAParkMHEfficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failureAm J Cardiol2004941475715566933
   PubMed Web of Science ®Google Scholar
• AldashevAAKojonazarovBKAmatovTAPhosphodiesterase type 5 and high altitude pulmonary hypertensionThorax200560683716061711
   PubMed Web of Science ®Google Scholar
• AlpSSchlottmannRBauerTTLong-time survival with hiv-related pulmonary arterial hypertension:A case reportAids2003171714512853763
   PubMed Web of Science ®Google Scholar
• BarstRJMcGoonMTorbickiADiagnosis and differential assessment of pulmonary arterial hypertensionJ Am Coll Cardiol20044340S7S15194177
   PubMed Web of Science ®Google Scholar
• BarstRJRubinLJLongWAA comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The primary pulmonary hypertension study groupN Engl J Med19963342963028532025
   PubMed Web of Science ®Google Scholar
• BasnyatBBMurdochDRDRHigh-altitude illnessLancet200336119677412801752
   PubMed Web of Science ®Google Scholar
• BharaniAMathewVSahuAThe efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertensionIndian Heart J20035555912760589
   PubMedGoogle Scholar
• BoolellMMGepi-AtteeSSGingellJJCSildenafil, a novel effective oral therapy for male erectile dysfunctionBr J Urol199678257618813924
   PubMedGoogle Scholar
• CarlsenJKjeldsenKGerstoftJSildenafil as a successful treatment of otherwise fatal hiv-related pulmonary hypertensionAids2002161568912131202
   PubMed Web of Science ®Google Scholar
• CastroOSystemic fat embolism and pulmonary hypertension in sickle cell diseaseHematol Oncol Clin North Am19961012893038956017
   PubMed Web of Science ®Google Scholar
• CastroPFBourgeRCMcGiffinDCIntrapulmonary shunting in primary pulmonary hypertension:An observation in two patients treated with epoprostenol sodiumChest199811433469674493
   PubMed Web of Science ®Google Scholar
• CastroOGladwinMTPulmonary hypertension in sickle cell disease:Mechanisms, diagnosis, and managementHematol Oncol Clin North Am20051988196vii16214649
   PubMed Web of Science ®Google Scholar
• CastroOHoqueMBrownBDPulmonary hypertension in sickle cell disease:Cardiac catheterization results and survivalBlood200310112576112393669
   PubMed Web of Science ®Google Scholar
• ChannickRNSimonneauGSitbonOEffects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension:A randomised placebo-controlled studyLancet200135811192311597664
   PubMed Web of Science ®Google Scholar
• ChaudhariMVogelMWrightCSildenafil in neonatal pulmonary hypertension due to impaired alveolarisation and plexiform pulmonary arteriopathyArch Dis Child Fetal Neonatal Ed200590F527816244212
   PubMed Web of Science ®Google Scholar
• ChicheJDSchlutsmeyerSMBlochDBAdenovirus-mediated gene transfer of cgmp-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cgmpJ Biol Chem199827334263719852090
   PubMed Web of Science ®Google Scholar
• ChuaRKeoghAMiyashitaMNovel use of sildenafil in the treatment of portopulmonary hypertensionJ Heart Lung Transplant20052449850015797756
   PubMed Web of Science ®Google Scholar
• Costard-JackleAFowlerMBInfluence of preoperative pulmonary artery pressure on mortality after heart transplantation:Testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk groupJ Am Coll Cardiol19921948541729345
   PubMed Web of Science ®Google Scholar
• D'AlonzoGEBarstRJAyresSMSurvival in patients with primary pulmonary hypertension. Results from a national prospective registryAnn Intern Med199111534391863023
   PubMed Web of Science ®Google Scholar
• DelgadoJFGomez-SanchezMASaenz de la CalzadaCImpact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantationJ Heart Lung Transplant200120942811557188
   PubMed Web of Science ®Google Scholar
• DerchiGForniGLFormisanoFEfficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathiesHaematologica200590452815820939
   PubMed Web of Science ®Google Scholar
• EricksonKWCostanzo-NordinMRO’SullivanEJInfluence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantationJ Heart Transplant19909526372231091
   PubMedGoogle Scholar
• FungEFiscusRRYimAPThe potential use of type-5 phosphodiesterase inhibitors in coronary artery bypass graft surgeryChest200512830657316236987
   PubMed Web of Science ®Google Scholar
• FusterVSteelePMEdwardsWDPrimary pulmonary hypertension:Natural history and the importance of thrombosisCirculation19847058076148159
   PubMed Web of Science ®Google Scholar
• GaniereVFeihlFTaganDDramatic beneficial effects of sildenafil in recurrent massive pulmonary embolismIntensive Care Med200632452416450094
   PubMed Web of Science ®Google Scholar
• GalièNGhofraniHATorbickiASildenafil citrate therapy for pulmonary arterial hypertensionN Engl J Med200535321485716291984
   PubMed Web of Science ®Google Scholar
• GalièNManesAUguccioniLPrimary pulmonary hypertension:Insights into pathogenesis from epidemiologyChest1998114184S94S9741567
   PubMed Web of Science ®Google Scholar
• GargUCHassidANitric oxide-generating vasodilators inhibit mitogenesis and proliferation of balb/c 3t3 fibroblasts by a cyclic gmp-independent mechanismBiochem Biophys Res Commun199017147491697465
   PubMed Web of Science ®Google Scholar
• GeRHelunGCurrent concept of chronic mountain sickness:Pulmonary hypertension-related high-altitude heart diseaseWilderness Environ Med200112190411562018
   PubMed Web of Science ®Google Scholar
• GhofraniHAReichenbergerFKohstallMGSildenafil increased exercise capacity during hypoxia at low altitudes and at mount everest base camp:A randomized, double-blind, placebo-controlled crossover trialAnn Intern Med20041411697715289213
   PubMed Web of Science ®Google Scholar
• GhofraniHARoseFSchermulyRTOral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertensionJ Am Coll Cardiol2003a421586412849677
   PubMed Web of Science ®Google Scholar
• GhofraniHASchermulyRTRoseFSildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertensionAm J Respir Crit Care Med2003b16711394112684251
   PubMed Web of Science ®Google Scholar
• GhofraniHAWiedemannRRoseFCombination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertensionAnn Intern Med2002a1365152211926786
   PubMed Web of Science ®Google Scholar
• GhofraniHAWiedemannRRoseFSildenafil for treatment of lung fibrosis and pulmonary hypertension:A randomised controlled trialLancet2002b36089590012354470
   PubMed Web of Science ®Google Scholar
• GhofraniHAWiedemannRRoseFSildenafil for treatment of lung fibrosis and pulmonary hypertension:A randomised controlled trialLancet2002c36089590012354470
   PubMed Web of Science ®Google Scholar
• GladwinMTSachdevVJisonMLPulmonary hypertension as a risk factor for death in patients with sickle cell diseaseN Engl J Med20043508869514985486
   PubMed Web of Science ®Google Scholar
• Gomberg-MaitlandMMcLaughlinVGulatiMEfficacy and safety of sildenafil added to treprostinil in pulmonary hypertensionAm J Cardiol2005961334616253609
   PubMed Web of Science ®Google Scholar
• Gómez-MorenoSLageEHernándezAUse of oral sildenafil in patients with irreversible pulmonary hypertension not eligible for heart transplantationTransplant Proc2005371550115866670
   PubMed Web of Science ®Google Scholar
• HaywardCSKellyRPMacdonaldPSInhaled nitric oxide in cardiology practiceCardiovasc Res1999436283810690334
   PubMed Web of Science ®Google Scholar
• HoeperMMDinh-XuanATCombination therapy for pulmonary arterial hypertension:Still more questions than answersEur Respir J20042433934015358685
   PubMed Web of Science ®Google Scholar
• HoeperMMMarkevychISpiekerkoetterEGoal-oriented treatment and combination therapy for pulmonary arterial hypertensionEur Respir J2005268586316264047
   PubMed Web of Science ®Google Scholar
• HoeperMMOlschewskiHGhofraniHAA comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German pph study groupJ Am Coll Cardiol2000351768210636277
   PubMed Web of Science ®Google Scholar
• HoeperMMOudizRJPeacockAEnd points and clinical trial designs in pulmonary arterial hypertension:Clinical and regulatory perspectivesJ Am Coll Cardiol20044348S55S15194178
   PubMed Web of Science ®Google Scholar
• HoeperMMWelteTIzbickiGSildenafil citrate therapy for pulmonary arterial hypertensionN Engl J Med20063541091316525151
   PubMedGoogle Scholar
• HonKLCheungKLSiuKLOral sildenafil for treatment of severe pulmonary hypertension in an infantBiol Neonate2005881091215870496
   PubMedGoogle Scholar
• HumplTReyesJTHoltbyHBeneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension:Twelve-month clinical trial of a single-drug, open-label, pilot studyCirculation200511132748015956137
   PubMed Web of Science ®Google Scholar
• IkedaDTsujinoIOhiraHAddition of oral sildenafil to beraprost is a safe and effective therapeutic option for patients with pulmonary hypertensionJ Cardiovasc Pharmacol200545286915772514
   PubMed Web of Science ®Google Scholar
• ItohTNagayaNFujiiTA combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in ratsAm J Respir Crit Care Med200416934814525801
   PubMed Web of Science ®Google Scholar
• JulianaAEAbbadFCSevere persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide:Successful treatment with sildenafilEur J Pediatr2005164626916012855
   PubMed Web of Science ®Google Scholar
• KingTEJr.ToozeJASchwarzMIPredicting survival in idiopathic pulmonary fibrosis:Scoring system and survival modelAm J Respir Crit Care Med200116411718111673205
   PubMed Web of Science ®Google Scholar
• KlingJFrom hypertension to angina to viagraModern Drug Discovery19981313343638
   Google Scholar
• KlonerRACardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunctionCirculation200411031495515533876
   PubMed Web of Science ®Google Scholar
• KumarSIndian doctor in protest after using Viagra to save “blue babies”BMJ200232518112142299
   PubMedGoogle Scholar
• LeeSHChannickRNEndothelin antagonism in pulmonary arterial hypertensionSemin Respir Crit Care Med200526402816121317
   PubMed Web of Science ®Google Scholar
• LeeSLWangWWFanburgBLNitroprusside inhibits serotonin-induced mitogenesis and tyrosine phosphorylation of smooth muscle cellsAm J Physiol1996270L36278638728
   PubMedGoogle Scholar
• LeporeJJMarooAPereiraNLEffect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertensionAm J Cardiol2002906778012231108
   PubMed Web of Science ®Google Scholar
• MachadoRFMartyrSKatoGJSildenafil therapy in patients with sickle cell disease and pulmonary hypertensionBr J Haematol20051304455316042696
   PubMed Web of Science ®Google Scholar
• MachadoRFGladwinMTChronic sickle cell lung disease:New insights into the diagnosis, pathogenesis and treatment of pulmonary hypertensionBr J Haematol20051294496415877728
   PubMed Web of Science ®Google Scholar
• MaddenBCrerar-GilbertAPulmonary hypertension and sildenafilBr J Anaesth20059556216155044
   PubMed Web of Science ®Google Scholar
• MakisaloHKoivusaloAVakkuriASildenafil for portopulmonary hypertension in a patient undergoing liver transplantationLiver Transpl2004109455015237383
   PubMed Web of Science ®Google Scholar
• McGwinGJrVaphiadesMSHallTANon-arteritic anterior ischaemic optic neuropathy and the treatment of erectile dysfunctionBr J Ophthalmol200690154716424524
   PubMed Web of Science ®Google Scholar
• McLaughlinVVShillingtonARichSSurvival in primary pulmonary hypertension:The impact of epoprostenol therapyCirculation200210614778212234951
   PubMed Web of Science ®Google Scholar
• MichelakisETymchakWLienDOral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension:Comparison with inhaled nitric oxideCirculation2002105239840312021227
   PubMed Web of Science ®Google Scholar
• MiyamotoSNagayaNSatohTClinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension . Comparison with cardiopulmonary exercise testingAm J Respir Crit Care Med20001614879210673190
   PubMed Web of Science ®Google Scholar
• MoralesAGingellCCollinsMClinical safety of oral sildenafil citrate (Viagra®) in the treatment of erectile dysfunctionInt J Impot Res19981069739647940
   PubMed Web of Science ®Google Scholar
• OsinskiMTRauchBHSchrorKAntimitogenic actions of organic nitrates are potentiated by sildenafil and mediated via activation of protein kinase aMol Pharmacol20015910445011306686
   PubMed Web of Science ®Google Scholar
• PauvertOLugnierCKeravisTEffect of sildenafil on cyclic nucleotide phosphodiesterase activity, vascular tone and calcium signaling in rat pulmonary arteryBr J Pharmacol20031395132212788811
   PubMed Web of Science ®Google Scholar
• PauvertOSalvailDRousseauECharacterisation of cyclic nucleotide phosphodiesterase isoforms in the media layer of the main pulmonary arteryBiochem Pharmacol20026317637212007579
   PubMed Web of Science ®Google Scholar
• PellicelliAMBarbaroGPalmieriFPrimary pulmonary hypertension in hiv patients: A systematic reviewAngiology200152314111205929
   PubMed Web of Science ®Google Scholar
• PietraGGEdwardsWDKayJMHistopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the national heart, lung, and blood institute, primary pulmonary hypertension registryCirculation19898011982062805258
   PubMed Web of Science ®Google Scholar
• PollmanMJYamadaTHoriuchiMVasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin iiCirc Res199679748568831498
   PubMed Web of Science ®Google Scholar
• RabeKFTenorHDentGIdentification of pde isozymes in human pulmonary artery and effect of selective pde inhibitorsAm J Physiol1994266L536437515580
   PubMed Web of Science ®Google Scholar
• ReichenbergerFVoswinckelRStevelingESildenafil treatment for portopulmonary hypertensionEur Respir J200628563716807265
   PubMed Web of Science ®Google Scholar
• ReiterCDWangXTanus-SantosJECell-free hemoglobin limits nitric oxide bioavailability in sickle-cell diseaseNat Med200281383912426562
   PubMed Web of Science ®Google Scholar
• RichSKaufmannELevyPSThe effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertensionN Engl J Med199232776811603139
   PubMed Web of Science ®Google Scholar
• RichaletJ-PGratadourPRobachPSildenafil inhibits altitude-induced hypoxemia and pulmonary hypertensionAm J Respir Crit Care Med20051712758115516532
   PubMed Web of Science ®Google Scholar
• RondeletBKerbaulFVan BenedenRSignaling molecules in overcirculation-induced pulmonary hypertension in piglets:Effects of sildenafil therapyCirculation20041102220515466636
   PubMed Web of Science ®Google Scholar
• RubinLJPrimary pulmonary hypertensionN Engl J Med199733611178988890
   PubMed Web of Science ®Google Scholar
• RubinLJBadeschDBBarstRJBosentan therapy for pulmonary arterial hypertensionN Engl J Med200234689690311907289
   PubMed Web of Science ®Google Scholar
• SastryBKSNarasimhanCReddyNKClinical efficacy of sildenafil in primary pulmonary hypertension:A randomized, placebo-controlled, double-blind, crossover studyJ Am Coll Cardiol20044311495315063421
   PubMed Web of Science ®Google Scholar
• SchäferABauersachsJHigh-altitude pulmonary edema:Potential protection by red wineNutr Metab Cardiovasc Dis2002123061012616811
   PubMed Web of Science ®Google Scholar
• SchermulyRTKreisselmeierKPGhofraniHAChronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in ratsAm J Resp Crit Care Med2004169394512958054
   PubMed Web of Science ®Google Scholar
• SchreiberMDGin-MestanKMarksJDInhaled nitric oxide in premature infants with the respiratory distress syndromeN Engl J Med2003349209910714645637
   PubMed Web of Science ®Google Scholar
• Schulze-NeickIHartensteinPLiJIntravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart diseaseCirculation2003108167II73
   Web of Science ®Google Scholar
• SchumacherYOZdebikAHuonkerMSildenafil in hiv-related pulmonary hypertensionAids2001151747811546958
   PubMed Web of Science ®Google Scholar
• SebkhiAStrangeJWPhillipsSCPhosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertensionCirculation20031073230512796132
   PubMed Web of Science ®Google Scholar
• SimonneauGGalieNRubinLJClinical classification of pulmonary hypertensionJ Am Coll Cardiol2004435S12S15194173
   PubMed Web of Science ®Google Scholar
• SitbonOHumbertMJaisXLong-term response to calcium channel blockers in idiopathic pulmonary arterial hypertensionCirculation200511131051115939821
   PubMed Web of Science ®Google Scholar
• SpeichRJenniROpravilMPrimary pulmonary hypertension in hiv infectionChest19911001268711935280
   PubMed Web of Science ®Google Scholar
• StockerCPennyDJBrizardCPIntravenous sildenafil and inhaled nitric oxide:A randomised trial in infants after cardiac surgeryIntensive Care Med2003291996200314530859
   PubMed Web of Science ®Google Scholar
• SuttonLLCastroOCrossDJPulmonary hypertension in sickle cell diseaseAm J Cardiol19947462688074054
   PubMed Web of Science ®Google Scholar
• TantiniBManesAFiumanaEAntiproliferative effect of sildenafil on human pulmonary artery smooth muscle cellsBasic Res Cardiol2005100131815739122
   PubMed Web of Science ®Google Scholar
• TrachteALLobatoEBUrdanetaFOral sildenafil reduces pulmonary hypertension after cardiac surgeryAnn Thorac Surg2005791947 discussion 194-715620942
   PubMed Web of Science ®Google Scholar
• TravadiJNPatoleSKPhosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn:A reviewPediatr Pulmonol2003365293514618646
   PubMed Web of Science ®Google Scholar
• WhartonJStrangeJWMollerGMOAntiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cellsAm J Respir Crit Care Med20051721051315817798
   PubMed Web of Science ®Google Scholar
• WilkinsMRPaulGAStrangeJWSildenafil versus endothelin receptor antagonist for pulmonary hypertension (seraph) studyAm J Respir Crit Care Med20051711292715750042
   PubMed Web of Science ®Google Scholar
• WongARRasoolAHAbidinNZSildenafil as treatment for human immunodeficiency virus-related pulmonary hypertension in a childJ Paediatr Child Health200642147816509918
   PubMed Web of Science ®Google Scholar